person

Sara D.

Country
Norway
Department
Center for Laboratory Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 10 partner sites.

Specializations

Metabolic Liver Disease & Fibrosis

Investigator focuses on non‑alcoholic steatohepatitis and related metabolic liver conditions.

  • Non‑alcoholic steatohepatitis (NASH)
  • Fibrosis progression
  • Metabolic risk factor integration

Research integrates hepatic inflammation, insulin resistance, and lipid metabolism.

Cardiovascular & Thrombotic Therapy

Clinical work includes acute coronary syndromes, ischemic stroke prevention, and anticoagulation strategies.

  • Acute myocardial infarction
  • Ischemic stroke
  • Anticoagulant comparative trials

Emphasis on balancing efficacy with bleeding risk in high‑risk populations.

Oncology & Targeted Cancer Therapies

Engagement with solid tumor and hematologic malignancies employing precision medicine.

  • Clear cell renal carcinoma
  • Metastatic prostate cancer
  • Rare and hard‑to‑treat cancers

Focus on biomarker‑driven treatment selection and novel combination regimens.

Autoimmune Cytopenias & Hematologic Immunology

Investigates immune‑mediated blood cell disorders and emerging biologic agents.

  • Immune thrombocytopenia (ITP)
  • Warm autoimmune hemolytic anemia
  • Autoimmune cytopenias

Targets include Fc‑receptor modulation and complement inhibition.

Infectious Diseases & Emerging Pathogens

Studies include viral respiratory infections and zoonotic outbreaks.

  • COVID‑19 therapeutics
  • Monkeypox virus disease
  • Respiratory viral infection management

Focus on antiviral efficacy and supportive care optimization.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.